The global medical device testing market size is estimated at USD 10.76 billion in 2025 and is predicted to reach around USD 23.95 billion by 2034, accelerating at a CAGR of 9.31% from 2025 to 2034. The Asia Pacific medical device testing market size surpassed USD 4.52 billion in 2025 and is expanding at a CAGR of 9.44% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medical Device Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Device Testing Market, by Service Type
8.1.1. Biocompatibility Tests
8.1.1.1. Market Revenue and Forecast
8.1.2. Chemistry Tests
8.1.2.1. Market Revenue and Forecast
8.1.3. Microbiology & Sterility Test
8.1.3.1. Market Revenue and Forecast
8.1.4. Package Validation
8.1.4.1. Market Revenue and Forecast
9.1. Medical Device Testing Market, by Phase Type
9.1.1. Preclinical
9.1.1.1. Market Revenue and Forecast
9.1.2. Large animal Research
9.1.2.1. Market Revenue and Forecast
9.1.3. Small animal Research
9.1.3.1. Market Revenue and Forecast
9.1.4. Clinical
9.1.5.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Service Type
10.1.2. Market Revenue and Forecast, by Phase Type
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Service Type
10.1.3.2. Market Revenue and Forecast, by Phase Type
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Service Type
10.1.4.2. Market Revenue and Forecast, by Phase Type
10.2. Europe
10.2.1. Market Revenue and Forecast, by Service Type
10.2.2. Market Revenue and Forecast, by Phase Type
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Service Type
10.2.3.2. Market Revenue and Forecast, by Phase Type
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Service Type
10.2.4.2. Market Revenue and Forecast, by Phase Type
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Service Type
10.2.5.2. Market Revenue and Forecast, by Phase Type
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Service Type
10.2.6.2. Market Revenue and Forecast, by Phase Type
10.3. APAC
10.3.1. Market Revenue and Forecast, by Service Type
10.3.2. Market Revenue and Forecast, by Phase Type
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Service Type
10.3.3.2. Market Revenue and Forecast, by Phase Type
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Service Type
10.3.4.2. Market Revenue and Forecast, by Phase Type
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Service Type
10.3.5.2. Market Revenue and Forecast, by Phase Type
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Service Type
10.3.6.2. Market Revenue and Forecast, by Phase Type
10.4. MEA
10.4.1. Market Revenue and Forecast, by Service Type
10.4.2. Market Revenue and Forecast, by Phase Type
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Service Type
10.4.3.2. Market Revenue and Forecast, by Phase Type
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Service Type
10.4.4.2. Market Revenue and Forecast, by Phase Type
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Service Type
10.4.5.2. Market Revenue and Forecast, by Phase Type
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Service Type
10.4.6.2. Market Revenue and Forecast, by Phase Type
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Service Type
10.5.2. Market Revenue and Forecast, by Phase Type
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Service Type
10.5.3.2. Market Revenue and Forecast, by Phase Type
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Service Type
10.5.4.2. Market Revenue and Forecast, by Phase Type
11.1. WuXi AppTec
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Intertek Group Plc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Pace Analytical Services LLC
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Eurofins Scientific
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. North America Science Associates Inc. (NAMSA)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Element Minnetonka
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Charles River Laboratories
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. TÜV SÜD
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Nelson Laboratories, LLC
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Laboratory Corporation of America Holdings
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample